nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP2C9—Bexarotene—hematologic cancer	0.0263	0.0385	CbGbCtD
Dextropropoxyphene—CYP3A7—Ifosfamide—hematologic cancer	0.0246	0.036	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0246	0.036	CbGbCtD
Dextropropoxyphene—CYP3A7—Imatinib—hematologic cancer	0.0235	0.0344	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0235	0.0344	CbGbCtD
Dextropropoxyphene—CYP2C8—Bortezomib—hematologic cancer	0.0231	0.0339	CbGbCtD
Dextropropoxyphene—CYP2D6—Lomustine—hematologic cancer	0.0224	0.0328	CbGbCtD
Dextropropoxyphene—CYP2C9—Idarubicin—hematologic cancer	0.0218	0.0319	CbGbCtD
Dextropropoxyphene—CYP2D6—Idarubicin—hematologic cancer	0.0199	0.0292	CbGbCtD
Dextropropoxyphene—CYP2C8—Ifosfamide—hematologic cancer	0.0177	0.026	CbGbCtD
Dextropropoxyphene—CYP2D6—Hydroxyurea—hematologic cancer	0.017	0.0248	CbGbCtD
Dextropropoxyphene—CYP2C9—Bortezomib—hematologic cancer	0.0161	0.0236	CbGbCtD
Dextropropoxyphene—CYP2C8—Nilotinib—hematologic cancer	0.0154	0.0225	CbGbCtD
Dextropropoxyphene—CYP3A4—Bexarotene—hematologic cancer	0.0153	0.0224	CbGbCtD
Dextropropoxyphene—CYP2D6—Bortezomib—hematologic cancer	0.0147	0.0216	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.0147	0.0215	CbGbCtD
Dextropropoxyphene—CYP3A7—Irinotecan—hematologic cancer	0.0147	0.0215	CbGbCtD
Dextropropoxyphene—CYP3A4—Busulfan—hematologic cancer	0.0142	0.0208	CbGbCtD
Dextropropoxyphene—CYP3A4—Lomustine—hematologic cancer	0.0142	0.0208	CbGbCtD
Dextropropoxyphene—CYP2C9—Thalidomide—hematologic cancer	0.0141	0.0206	CbGbCtD
Dextropropoxyphene—CYP2C9—Teniposide—hematologic cancer	0.0134	0.0196	CbGbCtD
Dextropropoxyphene—CYP3A7—Vincristine—hematologic cancer	0.0128	0.0188	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0128	0.0188	CbGbCtD
Dextropropoxyphene—CYP3A4—Thiotepa—hematologic cancer	0.0127	0.0186	CbGbCtD
Dextropropoxyphene—CYP2C9—Ifosfamide—hematologic cancer	0.0124	0.0181	CbGbCtD
Dextropropoxyphene—CYP2C9—Imatinib—hematologic cancer	0.0118	0.0173	CbGbCtD
Dextropropoxyphene—CYP2D6—Imatinib—hematologic cancer	0.0108	0.0158	CbGbCtD
Dextropropoxyphene—CYP2C9—Nilotinib—hematologic cancer	0.0107	0.0157	CbGbCtD
Dextropropoxyphene—CYP3A4—Methoxsalen—hematologic cancer	0.00986	0.0144	CbGbCtD
Dextropropoxyphene—CYP2D6—Nilotinib—hematologic cancer	0.00982	0.0144	CbGbCtD
Dextropropoxyphene—CYP2D6—Vinorelbine—hematologic cancer	0.00974	0.0143	CbGbCtD
Dextropropoxyphene—CYP3A7—Dexamethasone—hematologic cancer	0.00966	0.0142	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00966	0.0142	CbGbCtD
Dextropropoxyphene—CYP3A4—Bortezomib—hematologic cancer	0.00938	0.0137	CbGbCtD
Dextropropoxyphene—CYP3A4—Daunorubicin—hematologic cancer	0.00897	0.0131	CbGbCtD
Dextropropoxyphene—CYP2C8—Etoposide—hematologic cancer	0.00848	0.0124	CbGbCtD
Dextropropoxyphene—CYP3A4—Cytarabine—hematologic cancer	0.00791	0.0116	CbGbCtD
Dextropropoxyphene—CYP3A4—Teniposide—hematologic cancer	0.00779	0.0114	CbGbCtD
Dextropropoxyphene—CYP3A4—Ifosfamide—hematologic cancer	0.00719	0.0105	CbGbCtD
Dextropropoxyphene—CYP2C8—Dexamethasone—hematologic cancer	0.00697	0.0102	CbGbCtD
Dextropropoxyphene—CYP3A4—Imatinib—hematologic cancer	0.00687	0.0101	CbGbCtD
Dextropropoxyphene—CYP3A4—Ruxolitinib—hematologic cancer	0.00647	0.00948	CbGbCtD
Dextropropoxyphene—CYP3A4—Nilotinib—hematologic cancer	0.00624	0.00914	CbGbCtD
Dextropropoxyphene—CYP3A4—Vinorelbine—hematologic cancer	0.00619	0.00907	CbGbCtD
Dextropropoxyphene—CYP2C9—Cisplatin—hematologic cancer	0.00602	0.00881	CbGbCtD
Dextropropoxyphene—CYP2D6—Vinblastine—hematologic cancer	0.006	0.00879	CbGbCtD
Dextropropoxyphene—CYP3A4—Triamcinolone—hematologic cancer	0.00566	0.00829	CbGbCtD
Dextropropoxyphene—CYP3A4—Dasatinib—hematologic cancer	0.00552	0.00808	CbGbCtD
Dextropropoxyphene—CYP3A4—Mitoxantrone—hematologic cancer	0.00545	0.00798	CbGbCtD
Dextropropoxyphene—CYP2C9—Dexamethasone—hematologic cancer	0.00486	0.00712	CbGbCtD
Dextropropoxyphene—CYP3A4—Betamethasone—hematologic cancer	0.00486	0.00712	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisolone—hematologic cancer	0.00479	0.00702	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisone—hematologic cancer	0.00453	0.00663	CbGbCtD
Dextropropoxyphene—CYP2D6—Dexamethasone—hematologic cancer	0.00444	0.00651	CbGbCtD
Dextropropoxyphene—CYP3A4—Irinotecan—hematologic cancer	0.00429	0.00629	CbGbCtD
Dextropropoxyphene—CYP3A4—Vinblastine—hematologic cancer	0.00382	0.00559	CbGbCtD
Dextropropoxyphene—CYP3A4—Vincristine—hematologic cancer	0.00375	0.00549	CbGbCtD
Dextropropoxyphene—CYP2D6—Doxorubicin—hematologic cancer	0.00369	0.0054	CbGbCtD
Dextropropoxyphene—CYP3A4—Etoposide—hematologic cancer	0.00344	0.00503	CbGbCtD
Dextropropoxyphene—CYP3A4—Dexamethasone—hematologic cancer	0.00283	0.00414	CbGbCtD
Dextropropoxyphene—CYP3A4—Doxorubicin—hematologic cancer	0.00234	0.00343	CbGbCtD
Dextropropoxyphene—Disopyramide—SLC22A1—hematologic cancer	0.000308	0.192	CrCbGaD
Dextropropoxyphene—Toremifene—ESR1—hematologic cancer	0.000254	0.158	CrCbGaD
Dextropropoxyphene—Phenoxybenzamine—SLC22A1—hematologic cancer	0.000182	0.113	CrCbGaD
Dextropropoxyphene—Diphenhydramine—SLC22A1—hematologic cancer	0.000152	0.0949	CrCbGaD
Dextropropoxyphene—Toremifene—ABCB1—hematologic cancer	0.000108	0.0672	CrCbGaD
Dextropropoxyphene—Tamoxifen—ABCG2—hematologic cancer	0.000104	0.0645	CrCbGaD
Dextropropoxyphene—Tamoxifen—ESR1—hematologic cancer	0.000102	0.0632	CrCbGaD
Dextropropoxyphene—Propafenone—ABCB1—hematologic cancer	7.62e-05	0.0474	CrCbGaD
Dextropropoxyphene—Diarrhoea—Vincristine—hematologic cancer	7.46e-05	0.000285	CcSEcCtD
Dextropropoxyphene—Headache—Thalidomide—hematologic cancer	7.45e-05	0.000285	CcSEcCtD
Dextropropoxyphene—Asthenia—Gemcitabine—hematologic cancer	7.42e-05	0.000284	CcSEcCtD
Dextropropoxyphene—Dizziness—Ifosfamide—hematologic cancer	7.39e-05	0.000283	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Epirubicin—hematologic cancer	7.34e-05	0.000281	CcSEcCtD
Dextropropoxyphene—Vision blurred—Prednisone—hematologic cancer	7.31e-05	0.00028	CcSEcCtD
Dextropropoxyphene—Nausea—Thiotepa—hematologic cancer	7.3e-05	0.000279	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Etoposide—hematologic cancer	7.27e-05	0.000278	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Irinotecan—hematologic cancer	7.26e-05	0.000278	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Mitoxantrone—hematologic cancer	7.26e-05	0.000278	CcSEcCtD
Dextropropoxyphene—Vomiting—Carmustine—hematologic cancer	7.26e-05	0.000278	CcSEcCtD
Dextropropoxyphene—Insomnia—Triamcinolone—hematologic cancer	7.24e-05	0.000277	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Etoposide—hematologic cancer	7.22e-05	0.000276	CcSEcCtD
Dextropropoxyphene—Dizziness—Vincristine—hematologic cancer	7.21e-05	0.000276	CcSEcCtD
Dextropropoxyphene—Rash—Carmustine—hematologic cancer	7.2e-05	0.000275	CcSEcCtD
Dextropropoxyphene—Dermatitis—Carmustine—hematologic cancer	7.19e-05	0.000275	CcSEcCtD
Dextropropoxyphene—Vomiting—Alitretinoin—hematologic cancer	7.19e-05	0.000275	CcSEcCtD
Dextropropoxyphene—Drowsiness—Doxorubicin—hematologic cancer	7.18e-05	0.000275	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Prednisolone—hematologic cancer	7.18e-05	0.000275	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methotrexate—hematologic cancer	7.17e-05	0.000274	CcSEcCtD
Dextropropoxyphene—Headache—Carmustine—hematologic cancer	7.15e-05	0.000274	CcSEcCtD
Dextropropoxyphene—Shock—Betamethasone—hematologic cancer	7.15e-05	0.000274	CcSEcCtD
Dextropropoxyphene—Shock—Dexamethasone—hematologic cancer	7.15e-05	0.000274	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Triamcinolone—hematologic cancer	7.14e-05	0.000273	CcSEcCtD
Dextropropoxyphene—Rash—Alitretinoin—hematologic cancer	7.13e-05	0.000273	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Betamethasone—hematologic cancer	7.13e-05	0.000273	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Dexamethasone—hematologic cancer	7.13e-05	0.000273	CcSEcCtD
Dextropropoxyphene—Agitation—Prednisone—hematologic cancer	7.12e-05	0.000273	CcSEcCtD
Dextropropoxyphene—Dermatitis—Alitretinoin—hematologic cancer	7.12e-05	0.000273	CcSEcCtD
Dextropropoxyphene—Vomiting—Ifosfamide—hematologic cancer	7.11e-05	0.000272	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Cisplatin—hematologic cancer	7.1e-05	0.000272	CcSEcCtD
Dextropropoxyphene—Tachycardia—Dexamethasone—hematologic cancer	7.09e-05	0.000271	CcSEcCtD
Dextropropoxyphene—Tachycardia—Betamethasone—hematologic cancer	7.09e-05	0.000271	CcSEcCtD
Dextropropoxyphene—Bradycardia—Epirubicin—hematologic cancer	7.09e-05	0.000271	CcSEcCtD
Dextropropoxyphene—Headache—Alitretinoin—hematologic cancer	7.09e-05	0.000271	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Gemcitabine—hematologic cancer	7.07e-05	0.000271	CcSEcCtD
Dextropropoxyphene—Nausea—Thalidomide—hematologic cancer	7.06e-05	0.00027	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Triamcinolone—hematologic cancer	7.05e-05	0.00027	CcSEcCtD
Dextropropoxyphene—Rash—Ifosfamide—hematologic cancer	7.05e-05	0.00027	CcSEcCtD
Dextropropoxyphene—Dermatitis—Ifosfamide—hematologic cancer	7.04e-05	0.000269	CcSEcCtD
Dextropropoxyphene—Dizziness—Irinotecan—hematologic cancer	7.02e-05	0.000269	CcSEcCtD
Dextropropoxyphene—Jaundice—Doxorubicin—hematologic cancer	7e-05	0.000268	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Etoposide—hematologic cancer	6.98e-05	0.000267	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methotrexate—hematologic cancer	6.96e-05	0.000266	CcSEcCtD
Dextropropoxyphene—Syncope—Prednisone—hematologic cancer	6.95e-05	0.000266	CcSEcCtD
Dextropropoxyphene—Vomiting—Vincristine—hematologic cancer	6.93e-05	0.000265	CcSEcCtD
Dextropropoxyphene—Asthenia—Cisplatin—hematologic cancer	6.91e-05	0.000265	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Methotrexate—hematologic cancer	6.91e-05	0.000264	CcSEcCtD
Dextropropoxyphene—Rash—Vincristine—hematologic cancer	6.87e-05	0.000263	CcSEcCtD
Dextropropoxyphene—Dermatitis—Vincristine—hematologic cancer	6.87e-05	0.000263	CcSEcCtD
Dextropropoxyphene—Headache—Vincristine—hematologic cancer	6.83e-05	0.000261	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Prednisone—hematologic cancer	6.81e-05	0.000261	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—hematologic cancer	6.79e-05	0.00026	CcSEcCtD
Dextropropoxyphene—Hypotension—Dexamethasone—hematologic cancer	6.79e-05	0.00026	CcSEcCtD
Dextropropoxyphene—Hypotension—Betamethasone—hematologic cancer	6.79e-05	0.00026	CcSEcCtD
Dextropropoxyphene—Bepridil—ABCB1—hematologic cancer	6.79e-05	0.0422	CrCbGaD
Dextropropoxyphene—Nausea—Carmustine—hematologic cancer	6.78e-05	0.000259	CcSEcCtD
Dextropropoxyphene—Vomiting—Mitoxantrone—hematologic cancer	6.75e-05	0.000258	CcSEcCtD
Dextropropoxyphene—Vomiting—Irinotecan—hematologic cancer	6.75e-05	0.000258	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methotrexate—hematologic cancer	6.72e-05	0.000257	CcSEcCtD
Dextropropoxyphene—Nausea—Alitretinoin—hematologic cancer	6.72e-05	0.000257	CcSEcCtD
Dextropropoxyphene—Convulsion—Prednisone—hematologic cancer	6.72e-05	0.000257	CcSEcCtD
Dextropropoxyphene—Visual impairment—Epirubicin—hematologic cancer	6.71e-05	0.000257	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methotrexate—hematologic cancer	6.71e-05	0.000257	CcSEcCtD
Dextropropoxyphene—Rash—Irinotecan—hematologic cancer	6.69e-05	0.000256	CcSEcCtD
Dextropropoxyphene—Rash—Mitoxantrone—hematologic cancer	6.69e-05	0.000256	CcSEcCtD
Dextropropoxyphene—Dermatitis—Mitoxantrone—hematologic cancer	6.69e-05	0.000256	CcSEcCtD
Dextropropoxyphene—Dermatitis—Irinotecan—hematologic cancer	6.69e-05	0.000256	CcSEcCtD
Dextropropoxyphene—Headache—Mitoxantrone—hematologic cancer	6.65e-05	0.000254	CcSEcCtD
Dextropropoxyphene—Headache—Irinotecan—hematologic cancer	6.65e-05	0.000254	CcSEcCtD
Dextropropoxyphene—Nausea—Ifosfamide—hematologic cancer	6.64e-05	0.000254	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Triamcinolone—hematologic cancer	6.6e-05	0.000252	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Cisplatin—hematologic cancer	6.59e-05	0.000252	CcSEcCtD
Dextropropoxyphene—Vomiting—Gemcitabine—hematologic cancer	6.57e-05	0.000252	CcSEcCtD
Dextropropoxyphene—Insomnia—Betamethasone—hematologic cancer	6.57e-05	0.000251	CcSEcCtD
Dextropropoxyphene—Insomnia—Dexamethasone—hematologic cancer	6.57e-05	0.000251	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—hematologic cancer	6.56e-05	0.000251	CcSEcCtD
Dextropropoxyphene—Discomfort—Prednisone—hematologic cancer	6.52e-05	0.00025	CcSEcCtD
Dextropropoxyphene—Rash—Gemcitabine—hematologic cancer	6.52e-05	0.000249	CcSEcCtD
Dextropropoxyphene—Dermatitis—Gemcitabine—hematologic cancer	6.51e-05	0.000249	CcSEcCtD
Dextropropoxyphene—Eye disorder—Epirubicin—hematologic cancer	6.51e-05	0.000249	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Etoposide—hematologic cancer	6.5e-05	0.000249	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methotrexate—hematologic cancer	6.48e-05	0.000248	CcSEcCtD
Dextropropoxyphene—Headache—Gemcitabine—hematologic cancer	6.48e-05	0.000248	CcSEcCtD
Dextropropoxyphene—Nausea—Vincristine—hematologic cancer	6.47e-05	0.000248	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Epirubicin—hematologic cancer	6.46e-05	0.000247	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Prednisolone—hematologic cancer	6.42e-05	0.000245	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Betamethasone—hematologic cancer	6.4e-05	0.000245	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Dexamethasone—hematologic cancer	6.4e-05	0.000245	CcSEcCtD
Dextropropoxyphene—Asthenia—Etoposide—hematologic cancer	6.33e-05	0.000242	CcSEcCtD
Dextropropoxyphene—Nausea—Mitoxantrone—hematologic cancer	6.3e-05	0.000241	CcSEcCtD
Dextropropoxyphene—Nausea—Irinotecan—hematologic cancer	6.3e-05	0.000241	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Epirubicin—hematologic cancer	6.29e-05	0.000241	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Epirubicin—hematologic cancer	6.28e-05	0.00024	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.27e-05	0.00024	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.27e-05	0.00024	CcSEcCtD
Dextropropoxyphene—Fentanyl—ABCB1—hematologic cancer	6.24e-05	0.0388	CrCbGaD
Dextropropoxyphene—Shock—Prednisone—hematologic cancer	6.23e-05	0.000238	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Epirubicin—hematologic cancer	6.22e-05	0.000238	CcSEcCtD
Dextropropoxyphene—Visual impairment—Doxorubicin—hematologic cancer	6.21e-05	0.000238	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Prednisone—hematologic cancer	6.21e-05	0.000237	CcSEcCtD
Dextropropoxyphene—Tachycardia—Prednisone—hematologic cancer	6.18e-05	0.000236	CcSEcCtD
Dextropropoxyphene—Nausea—Gemcitabine—hematologic cancer	6.14e-05	0.000235	CcSEcCtD
Dextropropoxyphene—Vomiting—Cisplatin—hematologic cancer	6.13e-05	0.000234	CcSEcCtD
Dextropropoxyphene—Vision blurred—Methotrexate—hematologic cancer	6.11e-05	0.000234	CcSEcCtD
Dextropropoxyphene—Rash—Cisplatin—hematologic cancer	6.08e-05	0.000232	CcSEcCtD
Dextropropoxyphene—Dermatitis—Cisplatin—hematologic cancer	6.07e-05	0.000232	CcSEcCtD
Dextropropoxyphene—Malnutrition—Epirubicin—hematologic cancer	6.06e-05	0.000232	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Etoposide—hematologic cancer	6.04e-05	0.000231	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—hematologic cancer	6.02e-05	0.00023	CcSEcCtD
Dextropropoxyphene—Loperamide—ABCB1—hematologic cancer	6.01e-05	0.0374	CrCbGaD
Dextropropoxyphene—Feeling abnormal—Betamethasone—hematologic cancer	5.99e-05	0.000229	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Dexamethasone—hematologic cancer	5.99e-05	0.000229	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—hematologic cancer	5.98e-05	0.000229	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Betamethasone—hematologic cancer	5.94e-05	0.000227	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.94e-05	0.000227	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Triamcinolone—hematologic cancer	5.9e-05	0.000226	CcSEcCtD
Dextropropoxyphene—Dizziness—Etoposide—hematologic cancer	5.84e-05	0.000223	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—hematologic cancer	5.82e-05	0.000223	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—hematologic cancer	5.81e-05	0.000222	CcSEcCtD
Dextropropoxyphene—Dizziness—Prednisolone—hematologic cancer	5.76e-05	0.00022	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Doxorubicin—hematologic cancer	5.76e-05	0.00022	CcSEcCtD
Dextropropoxyphene—Asthenia—Triamcinolone—hematologic cancer	5.75e-05	0.00022	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Dexamethasone—hematologic cancer	5.74e-05	0.00022	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Betamethasone—hematologic cancer	5.74e-05	0.00022	CcSEcCtD
Dextropropoxyphene—Nausea—Cisplatin—hematologic cancer	5.72e-05	0.000219	CcSEcCtD
Dextropropoxyphene—Insomnia—Prednisone—hematologic cancer	5.72e-05	0.000219	CcSEcCtD
Dextropropoxyphene—Vision blurred—Epirubicin—hematologic cancer	5.71e-05	0.000219	CcSEcCtD
Dextropropoxyphene—Convulsion—Methotrexate—hematologic cancer	5.61e-05	0.000215	CcSEcCtD
Dextropropoxyphene—Vomiting—Etoposide—hematologic cancer	5.61e-05	0.000215	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—hematologic cancer	5.61e-05	0.000215	CcSEcCtD
Dextropropoxyphene—Agitation—Epirubicin—hematologic cancer	5.57e-05	0.000213	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Prednisone—hematologic cancer	5.57e-05	0.000213	CcSEcCtD
Dextropropoxyphene—Rash—Etoposide—hematologic cancer	5.57e-05	0.000213	CcSEcCtD
Dextropropoxyphene—Dermatitis—Etoposide—hematologic cancer	5.56e-05	0.000213	CcSEcCtD
Dextropropoxyphene—Headache—Etoposide—hematologic cancer	5.53e-05	0.000212	CcSEcCtD
Dextropropoxyphene—Rash—Prednisolone—hematologic cancer	5.49e-05	0.00021	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisolone—hematologic cancer	5.49e-05	0.00021	CcSEcCtD
Dextropropoxyphene—Headache—Prednisolone—hematologic cancer	5.45e-05	0.000209	CcSEcCtD
Dextropropoxyphene—Discomfort—Methotrexate—hematologic cancer	5.45e-05	0.000209	CcSEcCtD
Dextropropoxyphene—Syncope—Epirubicin—hematologic cancer	5.44e-05	0.000208	CcSEcCtD
Dextropropoxyphene—Constipation—Prednisone—hematologic cancer	5.41e-05	0.000207	CcSEcCtD
Dextropropoxyphene—Confusional state—Methotrexate—hematologic cancer	5.33e-05	0.000204	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Epirubicin—hematologic cancer	5.33e-05	0.000204	CcSEcCtD
Dextropropoxyphene—Dizziness—Triamcinolone—hematologic cancer	5.3e-05	0.000203	CcSEcCtD
Dextropropoxyphene—Vision blurred—Doxorubicin—hematologic cancer	5.29e-05	0.000202	CcSEcCtD
Dextropropoxyphene—Convulsion—Epirubicin—hematologic cancer	5.25e-05	0.000201	CcSEcCtD
Dextropropoxyphene—Nausea—Etoposide—hematologic cancer	5.24e-05	0.000201	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Prednisone—hematologic cancer	5.21e-05	0.0002	CcSEcCtD
Dextropropoxyphene—Asthenia—Betamethasone—hematologic cancer	5.21e-05	0.000199	CcSEcCtD
Dextropropoxyphene—Asthenia—Dexamethasone—hematologic cancer	5.21e-05	0.000199	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Methotrexate—hematologic cancer	5.19e-05	0.000198	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Prednisone—hematologic cancer	5.17e-05	0.000198	CcSEcCtD
Dextropropoxyphene—Nausea—Prednisolone—hematologic cancer	5.17e-05	0.000198	CcSEcCtD
Dextropropoxyphene—Agitation—Doxorubicin—hematologic cancer	5.16e-05	0.000197	CcSEcCtD
Dextropropoxyphene—Discomfort—Epirubicin—hematologic cancer	5.1e-05	0.000195	CcSEcCtD
Dextropropoxyphene—Vomiting—Triamcinolone—hematologic cancer	5.09e-05	0.000195	CcSEcCtD
Dextropropoxyphene—Rash—Triamcinolone—hematologic cancer	5.05e-05	0.000193	CcSEcCtD
Dextropropoxyphene—Dermatitis—Triamcinolone—hematologic cancer	5.04e-05	0.000193	CcSEcCtD
Dextropropoxyphene—Syncope—Doxorubicin—hematologic cancer	5.03e-05	0.000193	CcSEcCtD
Dextropropoxyphene—Headache—Triamcinolone—hematologic cancer	5.02e-05	0.000192	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Prednisone—hematologic cancer	5e-05	0.000191	CcSEcCtD
Dextropropoxyphene—Confusional state—Epirubicin—hematologic cancer	4.99e-05	0.000191	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Dexamethasone—hematologic cancer	4.97e-05	0.00019	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Betamethasone—hematologic cancer	4.97e-05	0.00019	CcSEcCtD
Dextropropoxyphene—Hypotension—Methotrexate—hematologic cancer	4.94e-05	0.000189	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—hematologic cancer	4.93e-05	0.000189	CcSEcCtD
Dextropropoxyphene—Shock—Epirubicin—hematologic cancer	4.87e-05	0.000186	CcSEcCtD
Dextropropoxyphene—Convulsion—Doxorubicin—hematologic cancer	4.86e-05	0.000186	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Epirubicin—hematologic cancer	4.85e-05	0.000186	CcSEcCtD
Dextropropoxyphene—Tachycardia—Epirubicin—hematologic cancer	4.83e-05	0.000185	CcSEcCtD
Dextropropoxyphene—Dizziness—Dexamethasone—hematologic cancer	4.8e-05	0.000184	CcSEcCtD
Dextropropoxyphene—Dizziness—Betamethasone—hematologic cancer	4.8e-05	0.000184	CcSEcCtD
Dextropropoxyphene—Insomnia—Methotrexate—hematologic cancer	4.78e-05	0.000183	CcSEcCtD
Dextropropoxyphene—Nausea—Triamcinolone—hematologic cancer	4.76e-05	0.000182	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—hematologic cancer	4.72e-05	0.000181	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Methotrexate—hematologic cancer	4.71e-05	0.00018	CcSEcCtD
Dextropropoxyphene—Somnolence—Methotrexate—hematologic cancer	4.7e-05	0.00018	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Prednisone—hematologic cancer	4.66e-05	0.000178	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Methotrexate—hematologic cancer	4.65e-05	0.000178	CcSEcCtD
Dextropropoxyphene—Hypotension—Epirubicin—hematologic cancer	4.62e-05	0.000177	CcSEcCtD
Dextropropoxyphene—Vomiting—Betamethasone—hematologic cancer	4.62e-05	0.000177	CcSEcCtD
Dextropropoxyphene—Vomiting—Dexamethasone—hematologic cancer	4.62e-05	0.000177	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—hematologic cancer	4.62e-05	0.000177	CcSEcCtD
Dextropropoxyphene—Rash—Dexamethasone—hematologic cancer	4.58e-05	0.000175	CcSEcCtD
Dextropropoxyphene—Rash—Betamethasone—hematologic cancer	4.58e-05	0.000175	CcSEcCtD
Dextropropoxyphene—Dermatitis—Dexamethasone—hematologic cancer	4.58e-05	0.000175	CcSEcCtD
Dextropropoxyphene—Dermatitis—Betamethasone—hematologic cancer	4.58e-05	0.000175	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.57e-05	0.000175	CcSEcCtD
Dextropropoxyphene—Headache—Betamethasone—hematologic cancer	4.55e-05	0.000174	CcSEcCtD
Dextropropoxyphene—Headache—Dexamethasone—hematologic cancer	4.55e-05	0.000174	CcSEcCtD
Dextropropoxyphene—Asthenia—Prednisone—hematologic cancer	4.54e-05	0.000174	CcSEcCtD
Dextropropoxyphene—Trimipramine—ABCB1—hematologic cancer	4.52e-05	0.0281	CrCbGaD
Dextropropoxyphene—Shock—Doxorubicin—hematologic cancer	4.5e-05	0.000172	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—hematologic cancer	4.49e-05	0.000172	CcSEcCtD
Dextropropoxyphene—Insomnia—Epirubicin—hematologic cancer	4.48e-05	0.000171	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—hematologic cancer	4.47e-05	0.000171	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Epirubicin—hematologic cancer	4.41e-05	0.000169	CcSEcCtD
Dextropropoxyphene—Somnolence—Epirubicin—hematologic cancer	4.4e-05	0.000168	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methotrexate—hematologic cancer	4.36e-05	0.000167	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Epirubicin—hematologic cancer	4.36e-05	0.000167	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Prednisone—hematologic cancer	4.33e-05	0.000166	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Methotrexate—hematologic cancer	4.32e-05	0.000165	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ABCB1—hematologic cancer	4.32e-05	0.0269	CrCbGaD
Dextropropoxyphene—Nausea—Betamethasone—hematologic cancer	4.32e-05	0.000165	CcSEcCtD
Dextropropoxyphene—Nausea—Dexamethasone—hematologic cancer	4.32e-05	0.000165	CcSEcCtD
Dextropropoxyphene—Methadone—ABCB1—hematologic cancer	4.28e-05	0.0266	CrCbGaD
Dextropropoxyphene—Hypotension—Doxorubicin—hematologic cancer	4.28e-05	0.000164	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.27e-05	0.000163	CcSEcCtD
Dextropropoxyphene—Constipation—Epirubicin—hematologic cancer	4.23e-05	0.000162	CcSEcCtD
Dextropropoxyphene—Dizziness—Prednisone—hematologic cancer	4.18e-05	0.00016	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Methotrexate—hematologic cancer	4.18e-05	0.00016	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—hematologic cancer	4.14e-05	0.000158	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Doxorubicin—hematologic cancer	4.08e-05	0.000156	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Epirubicin—hematologic cancer	4.08e-05	0.000156	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—hematologic cancer	4.07e-05	0.000156	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Epirubicin—hematologic cancer	4.05e-05	0.000155	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—hematologic cancer	4.03e-05	0.000154	CcSEcCtD
Dextropropoxyphene—Vomiting—Prednisone—hematologic cancer	4.02e-05	0.000154	CcSEcCtD
Dextropropoxyphene—Rash—Prednisone—hematologic cancer	3.99e-05	0.000153	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisone—hematologic cancer	3.99e-05	0.000153	CcSEcCtD
Dextropropoxyphene—Headache—Prednisone—hematologic cancer	3.96e-05	0.000152	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.95e-05	0.000151	CcSEcCtD
Dextropropoxyphene—Constipation—Doxorubicin—hematologic cancer	3.92e-05	0.00015	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Epirubicin—hematologic cancer	3.91e-05	0.00015	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methotrexate—hematologic cancer	3.9e-05	0.000149	CcSEcCtD
Dextropropoxyphene—Asthenia—Methotrexate—hematologic cancer	3.79e-05	0.000145	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—hematologic cancer	3.77e-05	0.000144	CcSEcCtD
Dextropropoxyphene—Nausea—Prednisone—hematologic cancer	3.76e-05	0.000144	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.74e-05	0.000143	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Epirubicin—hematologic cancer	3.65e-05	0.00014	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Doxorubicin—hematologic cancer	3.62e-05	0.000139	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methotrexate—hematologic cancer	3.62e-05	0.000138	CcSEcCtD
Dextropropoxyphene—Asthenia—Epirubicin—hematologic cancer	3.55e-05	0.000136	CcSEcCtD
Dextropropoxyphene—Dizziness—Methotrexate—hematologic cancer	3.5e-05	0.000134	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Epirubicin—hematologic cancer	3.39e-05	0.00013	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—hematologic cancer	3.37e-05	0.000129	CcSEcCtD
Dextropropoxyphene—Vomiting—Methotrexate—hematologic cancer	3.36e-05	0.000129	CcSEcCtD
Dextropropoxyphene—Rash—Methotrexate—hematologic cancer	3.33e-05	0.000128	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methotrexate—hematologic cancer	3.33e-05	0.000127	CcSEcCtD
Dextropropoxyphene—Headache—Methotrexate—hematologic cancer	3.31e-05	0.000127	CcSEcCtD
Dextropropoxyphene—Asthenia—Doxorubicin—hematologic cancer	3.29e-05	0.000126	CcSEcCtD
Dextropropoxyphene—Dizziness—Epirubicin—hematologic cancer	3.27e-05	0.000125	CcSEcCtD
Dextropropoxyphene—Vomiting—Epirubicin—hematologic cancer	3.15e-05	0.00012	CcSEcCtD
Dextropropoxyphene—Nausea—Methotrexate—hematologic cancer	3.14e-05	0.00012	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—hematologic cancer	3.13e-05	0.00012	CcSEcCtD
Dextropropoxyphene—Rash—Epirubicin—hematologic cancer	3.12e-05	0.000119	CcSEcCtD
Dextropropoxyphene—Dermatitis—Epirubicin—hematologic cancer	3.12e-05	0.000119	CcSEcCtD
Dextropropoxyphene—Headache—Epirubicin—hematologic cancer	3.1e-05	0.000119	CcSEcCtD
Dextropropoxyphene—Dizziness—Doxorubicin—hematologic cancer	3.03e-05	0.000116	CcSEcCtD
Dextropropoxyphene—Nausea—Epirubicin—hematologic cancer	2.94e-05	0.000112	CcSEcCtD
Dextropropoxyphene—Vomiting—Doxorubicin—hematologic cancer	2.91e-05	0.000111	CcSEcCtD
Dextropropoxyphene—Rash—Doxorubicin—hematologic cancer	2.89e-05	0.00011	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—hematologic cancer	2.88e-05	0.00011	CcSEcCtD
Dextropropoxyphene—Headache—Doxorubicin—hematologic cancer	2.87e-05	0.00011	CcSEcCtD
Dextropropoxyphene—Nausea—Doxorubicin—hematologic cancer	2.72e-05	0.000104	CcSEcCtD
Dextropropoxyphene—OPRK1—Signaling Pathways—BRAF—hematologic cancer	6.58e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HMMR—hematologic cancer	6.56e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—IDH2—hematologic cancer	6.56e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.56e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.56e-06	0.000121	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCL2—hematologic cancer	6.52e-06	0.00012	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL6R—hematologic cancer	6.5e-06	0.00012	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	6.49e-06	0.00012	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SDC1—hematologic cancer	6.47e-06	0.000119	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.46e-06	0.000119	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	6.45e-06	0.000119	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—JAK2—hematologic cancer	6.44e-06	0.000119	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SDC1—hematologic cancer	6.41e-06	0.000118	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	6.38e-06	0.000118	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYCS—hematologic cancer	6.34e-06	0.000117	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	6.31e-06	0.000116	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	6.3e-06	0.000116	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MDM2—hematologic cancer	6.29e-06	0.000116	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ESR1—hematologic cancer	6.26e-06	0.000115	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	6.2e-06	0.000114	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—FN1—hematologic cancer	6.18e-06	0.000114	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.17e-06	0.000114	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	6.16e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.12e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MTOR—hematologic cancer	6.12e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	6.12e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—BAD—hematologic cancer	6.11e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	6.11e-06	0.000113	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	6.1e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CG—hematologic cancer	6.09e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	6.05e-06	0.000112	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.04e-06	0.000111	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	6.03e-06	0.000111	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CA9—hematologic cancer	6e-06	0.000111	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ACP5—hematologic cancer	6e-06	0.000111	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CD80—hematologic cancer	5.93e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.92e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	5.92e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KIT—hematologic cancer	5.92e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	5.92e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—FGF2—hematologic cancer	5.89e-06	0.000109	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	5.84e-06	0.000108	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	5.81e-06	0.000107	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	5.81e-06	0.000107	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.78e-06	0.000107	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	5.74e-06	0.000106	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	5.68e-06	0.000105	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	5.67e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.67e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—JAK2—hematologic cancer	5.65e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CREBBP—hematologic cancer	5.64e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—IDH1—hematologic cancer	5.64e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CREB1—hematologic cancer	5.63e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CASP3—hematologic cancer	5.63e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL2—hematologic cancer	5.62e-06	0.000104	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL6—hematologic cancer	5.59e-06	0.000103	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTP1—hematologic cancer	5.58e-06	0.000103	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TXN—hematologic cancer	5.58e-06	0.000103	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.58e-06	0.000103	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.58e-06	0.000103	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—BRAF—hematologic cancer	5.56e-06	0.000103	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	5.54e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MDM2—hematologic cancer	5.51e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCL2—hematologic cancer	5.51e-06	0.000102	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CD44—hematologic cancer	5.5e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NQO1—hematologic cancer	5.5e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL6R—hematologic cancer	5.49e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	5.49e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCND1—hematologic cancer	5.48e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—JUN—hematologic cancer	5.47e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.46e-06	0.000101	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CD44—hematologic cancer	5.45e-06	0.0001	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NQO1—hematologic cancer	5.45e-06	0.0001	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.4e-06	9.96e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	5.37e-06	9.89e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MTOR—hematologic cancer	5.37e-06	9.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CD—hematologic cancer	5.35e-06	9.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.34e-06	9.84e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	5.3e-06	9.77e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PTEN—hematologic cancer	5.29e-06	9.75e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ABCB1—hematologic cancer	5.29e-06	9.75e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ALB—hematologic cancer	5.28e-06	9.74e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.24e-06	9.67e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	5.24e-06	9.66e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	5.2e-06	9.59e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYCS—hematologic cancer	5.2e-06	9.59e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	5.17e-06	9.54e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	5.17e-06	9.53e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	5.16e-06	9.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYCS—hematologic cancer	5.16e-06	9.51e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	5.15e-06	9.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NCOR1—hematologic cancer	5.13e-06	9.46e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTM1—hematologic cancer	5.13e-06	9.46e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.12e-06	9.45e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	5.12e-06	9.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.1e-06	9.41e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.1e-06	9.41e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	5.09e-06	9.39e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3R1—hematologic cancer	5.05e-06	9.32e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EP300—hematologic cancer	5.04e-06	9.3e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	5.03e-06	9.28e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—FGF2—hematologic cancer	4.98e-06	9.18e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	4.98e-06	9.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.97e-06	9.17e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CASP3—hematologic cancer	4.93e-06	9.1e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL2—hematologic cancer	4.93e-06	9.08e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	4.91e-06	9.06e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SRC—hematologic cancer	4.9e-06	9.04e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL6—hematologic cancer	4.9e-06	9.04e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NUP98—hematologic cancer	4.81e-06	8.88e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCND1—hematologic cancer	4.8e-06	8.86e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—JUN—hematologic cancer	4.79e-06	8.84e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	4.78e-06	8.8e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—JAK2—hematologic cancer	4.77e-06	8.8e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—STAT3—hematologic cancer	4.73e-06	8.72e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NRAS—hematologic cancer	4.72e-06	8.7e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	4.68e-06	8.63e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.67e-06	8.62e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.67e-06	8.62e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CB—hematologic cancer	4.66e-06	8.6e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MDM2—hematologic cancer	4.66e-06	8.59e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	4.65e-06	8.57e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NUP214—hematologic cancer	4.64e-06	8.56e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PTEN—hematologic cancer	4.64e-06	8.55e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.61e-06	8.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.58e-06	8.45e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MTR—hematologic cancer	4.55e-06	8.38e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.55e-06	8.38e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.55e-06	8.38e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—MTHFR—hematologic cancer	4.54e-06	8.36e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	4.54e-06	8.36e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MTOR—hematologic cancer	4.53e-06	8.36e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	4.53e-06	8.36e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	4.52e-06	8.34e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	4.52e-06	8.33e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ENO2—hematologic cancer	4.46e-06	8.22e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EP300—hematologic cancer	4.42e-06	8.15e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.4e-06	8.11e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MYC—hematologic cancer	4.39e-06	8.1e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	4.38e-06	8.08e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.34e-06	8e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	4.33e-06	7.98e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.32e-06	7.97e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.3e-06	7.93e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SRC—hematologic cancer	4.3e-06	7.93e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	4.26e-06	7.85e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SDC1—hematologic cancer	4.23e-06	7.79e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NCOR1—hematologic cancer	4.21e-06	7.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTM1—hematologic cancer	4.21e-06	7.77e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	4.21e-06	7.76e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	4.19e-06	7.72e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.18e-06	7.7e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.18e-06	7.7e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CASP3—hematologic cancer	4.17e-06	7.69e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL2—hematologic cancer	4.16e-06	7.68e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—STAT3—hematologic cancer	4.15e-06	7.64e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL6—hematologic cancer	4.14e-06	7.64e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NRAS—hematologic cancer	4.14e-06	7.63e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KRAS—hematologic cancer	4.06e-06	7.49e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCND1—hematologic cancer	4.06e-06	7.48e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—JUN—hematologic cancer	4.05e-06	7.47e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTEN—hematologic cancer	4.03e-06	7.43e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4e-06	7.37e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	3.96e-06	7.3e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	3.93e-06	7.24e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PTEN—hematologic cancer	3.92e-06	7.22e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MYC—hematologic cancer	3.85e-06	7.1e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—EP300—hematologic cancer	3.84e-06	7.09e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	3.84e-06	7.09e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	3.83e-06	7.07e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	3.82e-06	7.05e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.81e-06	7.03e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EP300—hematologic cancer	3.74e-06	6.89e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	3.73e-06	6.88e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.72e-06	6.87e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.69e-06	6.81e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SRC—hematologic cancer	3.63e-06	6.7e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TP53—hematologic cancer	3.61e-06	6.65e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NQO1—hematologic cancer	3.59e-06	6.63e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CD44—hematologic cancer	3.59e-06	6.63e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KRAS—hematologic cancer	3.56e-06	6.56e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	3.54e-06	6.53e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.53e-06	6.51e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—STAT3—hematologic cancer	3.5e-06	6.46e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NRAS—hematologic cancer	3.5e-06	6.45e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HRAS—hematologic cancer	3.45e-06	6.36e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYCS—hematologic cancer	3.4e-06	6.27e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.38e-06	6.23e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CD—hematologic cancer	3.35e-06	6.18e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	3.35e-06	6.17e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ALB—hematologic cancer	3.31e-06	6.1e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL6—hematologic cancer	3.3e-06	6.09e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	3.27e-06	6.03e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MYC—hematologic cancer	3.26e-06	6e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.25e-06	6e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	3.25e-06	5.99e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TP53—hematologic cancer	3.16e-06	5.83e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3R1—hematologic cancer	3.16e-06	5.83e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CG—hematologic cancer	3.13e-06	5.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.1e-06	5.72e-05	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—AKT1—hematologic cancer	3.05e-06	5.62e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HRAS—hematologic cancer	3.03e-06	5.58e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KRAS—hematologic cancer	3.01e-06	5.55e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTP1—hematologic cancer	3e-06	5.53e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.92e-06	5.38e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.9e-06	5.35e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL6—hematologic cancer	2.9e-06	5.34e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.88e-06	5.3e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.84e-06	5.24e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.84e-06	5.23e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	2.76e-06	5.1e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.75e-06	5.08e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.75e-06	5.08e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.75e-06	5.07e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.73e-06	5.03e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ALB—hematologic cancer	2.72e-06	5.01e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ALB—hematologic cancer	2.69e-06	4.96e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TP53—hematologic cancer	2.67e-06	4.93e-05	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—AKT1—hematologic cancer	2.67e-06	4.93e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.6e-06	4.79e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.57e-06	4.75e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HRAS—hematologic cancer	2.56e-06	4.72e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTEN—hematologic cancer	2.52e-06	4.65e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL6—hematologic cancer	2.45e-06	4.51e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.43e-06	4.49e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—EP300—hematologic cancer	2.41e-06	4.44e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.4e-06	4.42e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.38e-06	4.38e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—AKT1—hematologic cancer	2.32e-06	4.28e-05	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—AKT1—hematologic cancer	2.26e-06	4.16e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTEN—hematologic cancer	2.07e-06	3.82e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTEN—hematologic cancer	2.05e-06	3.79e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.05e-06	3.77e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—EP300—hematologic cancer	1.98e-06	3.64e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—EP300—hematologic cancer	1.96e-06	3.61e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.9e-06	3.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.8e-06	3.32e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.78e-06	3.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ALB—hematologic cancer	1.78e-06	3.27e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.7e-06	3.13e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.57e-06	2.89e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.46e-06	2.69e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—AKT1—hematologic cancer	1.45e-06	2.68e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.45e-06	2.67e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTEN—hematologic cancer	1.35e-06	2.5e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—EP300—hematologic cancer	1.29e-06	2.38e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—AKT1—hematologic cancer	1.19e-06	2.2e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—AKT1—hematologic cancer	1.18e-06	2.18e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.55e-07	1.76e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—AKT1—hematologic cancer	7.81e-07	1.44e-05	CbGpPWpGaD
